ES2086585T3 - Benzomorfanos y su empleo como medicamentos. - Google Patents

Benzomorfanos y su empleo como medicamentos.

Info

Publication number
ES2086585T3
ES2086585T3 ES92110923T ES92110923T ES2086585T3 ES 2086585 T3 ES2086585 T3 ES 2086585T3 ES 92110923 T ES92110923 T ES 92110923T ES 92110923 T ES92110923 T ES 92110923T ES 2086585 T3 ES2086585 T3 ES 2086585T3
Authority
ES
Spain
Prior art keywords
alkyl
acyl
aryl
benzomorphanes
medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92110923T
Other languages
English (en)
Inventor
Adrian Dr Carter
Helmut Dr Dipl-Chem Ensinger
Matthias Dr Dipl-Chem Grauert
Franz Josef Dr Kuhn
Herbert Dr Dipl-Chem Merz
Enzio Prof Dr Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim GmbH
Original Assignee
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim GmbH filed Critical Boehringer Ingelheim GmbH
Application granted granted Critical
Publication of ES2086585T3 publication Critical patent/ES2086585T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/26—Benzomorphans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A DERIVADOS BENZOMORFANOS DE LA FORMULA GENERAL I SU FABRICACION Y SU UTILIZACION COMO MEDICAMENTO EN EL TRATAMIENTO DE LA ISQUEMIA CEREBRAL DE DISTINTAS GENESIS, EPILEPSIA Y ENFERMEDADES NEURODEGENERATIVAS.
ES92110923T 1991-07-02 1992-06-27 Benzomorfanos y su empleo como medicamentos. Expired - Lifetime ES2086585T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4121821A DE4121821A1 (de) 1991-07-02 1991-07-02 Neue benzomorphane und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
ES2086585T3 true ES2086585T3 (es) 1996-07-01

Family

ID=6435223

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92110923T Expired - Lifetime ES2086585T3 (es) 1991-07-02 1992-06-27 Benzomorfanos y su empleo como medicamentos.

Country Status (24)

Country Link
EP (1) EP0521422B1 (es)
JP (1) JP3324785B2 (es)
KR (1) KR100251256B1 (es)
AT (1) ATE137749T1 (es)
AU (1) AU657330B2 (es)
CA (1) CA2072814C (es)
CZ (1) CZ286949B6 (es)
DE (2) DE4121821A1 (es)
DK (1) DK0521422T3 (es)
ES (1) ES2086585T3 (es)
FI (1) FI105913B (es)
GR (1) GR3020124T3 (es)
HK (1) HK1003111A1 (es)
HU (1) HU220873B1 (es)
IE (1) IE74400B1 (es)
IL (1) IL102361A (es)
MX (1) MX9203845A (es)
NO (1) NO178263C (es)
NZ (1) NZ243388A (es)
PH (1) PH31430A (es)
SG (1) SG43001A1 (es)
SK (1) SK280776B6 (es)
TW (1) TW214547B (es)
ZA (1) ZA924883B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19528472A1 (de) * 1995-08-03 1997-02-06 Boehringer Ingelheim Kg Neues Verfahren zur Herstellung von Norbenzomorphan einer Zwischenstufe bei Herstellung von pharmazeutisch wertvollen Benzomorphanderivaten, insbesondere von (-)-(1R,5S,S"R)-3'-Hydroxy-2-(2-methoxypropyl-)-5,9,9-trimethyl-6,7 benzomorphan
DE19740110A1 (de) * 1997-09-12 1999-03-18 Boehringer Ingelheim Pharma Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
JPH1196519A (ja) * 1997-09-17 1999-04-09 Alps Electric Co Ltd スピンバルブ型薄膜素子およびその製造方法
US6136980A (en) * 1998-05-01 2000-10-24 Boehringer Ingelheim Kg Method of preparing norbenzomorphane as an intermediate in the preparation of pharmaceutically useful benzomorphane derivatives, in particular (-)-(1R,5S,2"R)-3'-hydroxy-2-(2-methoxypropyl)-5,9,9-trimethyl-6,7-benzo morphane
DE19826365A1 (de) * 1998-06-12 1999-12-16 Gruenenthal Gmbh Verwendung von Benzomorphanderivaten als Analgetikum
US6355652B1 (en) 1999-11-27 2002-03-12 Boehringer Ingelheim Pharma Kg Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions
DE19957156A1 (de) * 1999-11-27 2001-05-31 Boehringer Ingelheim Pharma Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel
DE10204276A1 (de) * 2002-02-02 2003-08-07 Boehringer Ingelheim Pharma N-Allyloxyethyl-1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel
MXPA04011327A (es) 2002-05-17 2005-08-15 Jenken Biosciences Inc Opioides y compuestos similares a opioides y usos de los mismos.
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8859580B2 (en) * 2007-11-16 2014-10-14 Boehringer Ingelheim International Gmbh Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
WO2015097545A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7804509A (nl) * 1978-04-26 1979-10-30 Acf Chemiefarma Nv Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan.
DE2828039A1 (de) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
NL7907800A (nl) * 1979-10-23 1981-04-27 Acf Chemiefarma Nv Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan, farmaceutische preparaten die een dergelijke verbinding bevatten, alsmede werkwijze voor het bereiden van deze verbindingen en de farmaceutische preparaten.

Also Published As

Publication number Publication date
SK280776B6 (sk) 2000-07-11
NO922603L (no) 1993-01-04
CA2072814C (en) 2003-09-23
AU657330B2 (en) 1995-03-09
JPH05201987A (ja) 1993-08-10
ATE137749T1 (de) 1996-05-15
FI923050A0 (fi) 1992-07-01
EP0521422A1 (de) 1993-01-07
IL102361A (en) 1997-02-18
DK0521422T3 (da) 1996-06-10
KR930002321A (ko) 1993-02-22
CZ286949B6 (cs) 2000-08-16
JP3324785B2 (ja) 2002-09-17
HU9202199D0 (en) 1992-10-28
CA2072814A1 (en) 1993-01-03
SG43001A1 (en) 1997-10-17
FI105913B (fi) 2000-10-31
IE74400B1 (en) 1997-07-30
NZ243388A (en) 1994-11-25
EP0521422B1 (de) 1996-05-08
HK1003111A1 (en) 1998-10-09
HUT66410A (en) 1994-11-28
CZ207592A3 (en) 1993-08-11
MX9203845A (es) 1993-01-01
DE59206212D1 (de) 1996-06-13
SK207592A3 (en) 1997-01-08
NO922603D0 (no) 1992-07-01
KR100251256B1 (ko) 2000-05-01
IL102361A0 (en) 1993-01-14
ZA924883B (en) 1993-02-24
PH31430A (en) 1998-11-03
AU1868692A (en) 1993-01-07
DE4121821A1 (de) 1993-01-14
NO178263B (no) 1995-11-13
FI923050A (fi) 1993-01-03
NO178263C (no) 1996-02-21
GR3020124T3 (en) 1996-08-31
TW214547B (es) 1993-10-11
IE922144A1 (en) 1993-01-13
HU220873B1 (en) 2002-06-29

Similar Documents

Publication Publication Date Title
ES2086585T3 (es) Benzomorfanos y su empleo como medicamentos.
PA8510101A1 (es) Agentes antibacterianos de 3-aminoquinazolin-2,4 dionas.
NL350077I1 (nl) Cyprosulfamide
DK0765327T3 (da) Pyrazolo- og pyrrolopyridiner
DE69716925D1 (de) Isoxazoline derivate und ihre verwendung als antimikroben
CY1107830T1 (el) Αντικαρκινικα αναλογα
DK0671156T3 (da) Kosmetiske eller farmaceutiske præparater indeholdende liposomer
FI941324A0 (fi) 10-desasetoksitaksolijohdannaisia
MX9805181A (es) Derivados de lactona a partir de derivados de 17.beta- carboxi, carbotio y amida androstano.
NO912940L (no) Immunundertrykkende middel og fremgangsmaate for fremstilling av samme.
ES2177656T3 (es) Derivados de antraciclinona y su utilizacion en el tratamiento de la amiloidosis.
SE0004480D0 (sv) Novel compounds
SE0002330D0 (sv) Novel compounds

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 521422

Country of ref document: ES